CD49d plays a critical role in leucocyte trafficking, activation and survival, and facilitates
interactions between leucocytes and stromal cells. Recent data give evidence for the …

In vitro studies have demonstrated that surface expression of CD49d on chronic lymphocytic
leukaemia (CLL) B cells facilitates leukaemic cell–stromal interactions by binding to …

CD49d/α4-integrin is variably expressed in chronic lymphocytic leukemia (CLL). We
evaluated its relevance as independent prognosticator for overall survival and time to …

CD49d is a remarkable prognostic biomarker of chronic lymphocytic leukemia (CLL). The
cutoff value for the extensively validated 30% of positive CLL cells is able to separate CLL …

OBJECTIVE: The aim of this study was to assess the prognostic value of CD49d expression
in Turkish chronic lymphocytic leukemia patients. METHODS: Data for 118 patients from a …

Evaluation of: Shanafelt TD, Geyer SM, Bone ND et al.: CD49d expression is an
independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a …

CLL is characterized by extremely variable clinical course. Several prognostic factors can
predict disease progression and therapeutic outcomes in those patients. The aim was to …

Identification of prognosticators for Binet A chronic lymphocytic leukemia is important for
selecting patients with dismal prognosis. We analyzed CD49d expression in 140 …

Heterogeneity of CD 20 expression exists in chronic lymphocytic leukemia (CLL), therefore,
we explored the prognostic significance of CD 20 expression in Chinese patients with CLL …

CD49d is a negative prognosticator in chronic lymphocytic leukemia (CLL), expressed by∼
40% of CLL cases and associated with aggressive, accelerated clinical courses. In this …